Listen to this page using ReadSpeaker

Delaware News


  Category: Consumer Protection


Delaware Attorney General Matt Denn Announces Settlement With Western Union

Consumer Protection | Department of Justice | Department of Justice Press Releases | Date Posted: Tuesday, January 31, 2017

Attorney General Matt Denn along with the attorneys general of 48 states and the District of Columbia Tuesday announced a settlement with Colorado-based The Western Union Company (“Western Union”) to resolve a multistate investigation focused on complaints of consumers who used Western Union’s wire transfer service to send money to third parties involved in schemes […]



Delaware Weighs In To Case On Independence of Federal Consumer Protection Agency

Consumer Protection | Department of Justice | Department of Justice Press Releases | Date Posted: Monday, January 23, 2017

Attorney General Matt Denn joined 16 other attorneys general in filing a motion Monday to intervene in a federal appeals case, with the goal of ensuring that the federal Consumer Financial Protection Bureau (CFPB) remains independent and able to aggressively defend the interests of American consumers free from political pressure from the White House. The […]



Moody’s Agrees to Settlement With States and Federal Government Over Securities Ratings

Consumer Protection | Department of Justice | Department of Justice Press Releases | Fraud | Investor Protection | Date Posted: Friday, January 13, 2017

States, USDOJ Alleged Moody’s Inflated Ratings and Contributed To Market Crash. Attorney General Matt Denn joined the U.S. Department of Justice and 20 other attorneys general in announcing a settlement resolving an investigation into Moody’s Corporation, Moody’s Investors Service, Inc., and Moody’s Analytics, Inc. (collectively “Moody’s”) over the companies’ misrepresentations regarding the independence and objectivity […]



Delaware and 19 Other States File Federal Antitrust Lawsuit Against Six Generic Drug Companies

Consumer Protection | Department of Justice | Department of Justice Press Releases | Fraud | Date Posted: Thursday, December 15, 2016

States allege widespread conspiracy among competitors to reduce competition, increase prices for numerous generic prescription drugs Attorney General Matt Denn Thursday joined with 19 other state attorneys general in filing a federal lawsuit against generic drug-maker Heritage Pharmaceuticals, Inc., Auribindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva […]



Forty-Three Attorneys General Reach Consumer Protection Settlement With Bristol-Myers Squibb Company Over Abilify Marketing

Consumer Protection | Department of Justice | Department of Justice Press Releases | Date Posted: Thursday, December 8, 2016

Delaware Attorney General Matt Denn and 42 other Attorneys General have reached a settlement with Bristol-Myers Squibb Company (“BMS”) related to the drug company’s alleged improper marketing of Abilify, an atypical antipsychotic drug. An administrative complaint filed today along with a settlement agreement alleges that BMS engaged in deceptive trade practices when it marketed Abilify. […]






  Category: Consumer Protection

Delaware Attorney General Matt Denn Announces Settlement With Western Union

Consumer Protection | Department of Justice | Department of Justice Press Releases | Date Posted: Tuesday, January 31, 2017

Attorney General Matt Denn along with the attorneys general of 48 states and the District of Columbia Tuesday announced a settlement with Colorado-based The Western Union Company (“Western Union”) to resolve a multistate investigation focused on complaints of consumers who used Western Union’s wire transfer service to send money to third parties involved in schemes […]



Delaware Weighs In To Case On Independence of Federal Consumer Protection Agency

Consumer Protection | Department of Justice | Department of Justice Press Releases | Date Posted: Monday, January 23, 2017

Attorney General Matt Denn joined 16 other attorneys general in filing a motion Monday to intervene in a federal appeals case, with the goal of ensuring that the federal Consumer Financial Protection Bureau (CFPB) remains independent and able to aggressively defend the interests of American consumers free from political pressure from the White House. The […]



Moody’s Agrees to Settlement With States and Federal Government Over Securities Ratings

Consumer Protection | Department of Justice | Department of Justice Press Releases | Fraud | Investor Protection | Date Posted: Friday, January 13, 2017

States, USDOJ Alleged Moody’s Inflated Ratings and Contributed To Market Crash. Attorney General Matt Denn joined the U.S. Department of Justice and 20 other attorneys general in announcing a settlement resolving an investigation into Moody’s Corporation, Moody’s Investors Service, Inc., and Moody’s Analytics, Inc. (collectively “Moody’s”) over the companies’ misrepresentations regarding the independence and objectivity […]



Delaware and 19 Other States File Federal Antitrust Lawsuit Against Six Generic Drug Companies

Consumer Protection | Department of Justice | Department of Justice Press Releases | Fraud | Date Posted: Thursday, December 15, 2016

States allege widespread conspiracy among competitors to reduce competition, increase prices for numerous generic prescription drugs Attorney General Matt Denn Thursday joined with 19 other state attorneys general in filing a federal lawsuit against generic drug-maker Heritage Pharmaceuticals, Inc., Auribindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva […]



Forty-Three Attorneys General Reach Consumer Protection Settlement With Bristol-Myers Squibb Company Over Abilify Marketing

Consumer Protection | Department of Justice | Department of Justice Press Releases | Date Posted: Thursday, December 8, 2016

Delaware Attorney General Matt Denn and 42 other Attorneys General have reached a settlement with Bristol-Myers Squibb Company (“BMS”) related to the drug company’s alleged improper marketing of Abilify, an atypical antipsychotic drug. An administrative complaint filed today along with a settlement agreement alleges that BMS engaged in deceptive trade practices when it marketed Abilify. […]